RUBICON TECHNOLOGY LAUNCHES DIRECT DOSE RX – A DIRECT TO PATIENT PHARMACY SOLUTION
23 Maio 2019 - 5:01PM
Rubicon Technology, Inc. (Nasdaq: RBCN) announced today it
has acquired certain equipment and assets from a large Indiana
based pharmacy operation, including its licenses to operate in 11
states. In addition to the acquired assets, Rubicon hired their
highly skilled employees and was able to maintain the necessary
licenses to continue to operate the pharmacy operations. Rubicon
DTP LLC, a newly formed wholly owned subsidiary of Rubicon
Technology, will primarily operate this business under the name
Direct Dose Rx.
Direct Dose Rx is focused on the delivery of
prescription medication, over-the-counter drugs and vitamins to
skilled nursing facilities and hospitals for patients that are
being discharged. Direct Dose Rx also intends to service retail
customers who have monthly needs for multiple prescriptions,
over-the-counter drugs and vitamins and who wants such medications
delivered to their home. The delivered products are sorted by the
dose, date and time to be taken and come in an easy to use
perforated strip-packaging as opposed to separate pill bottles.
The services offered by Direct Dose Rx benefits
patients, skilled nursing facilities and hospitals by dramatically
reducing the risk of hospital readmissions.
“I am looking forward to working with the team
at Direct Dose Rx to build a world class pharmacy operation that
utilizes a transformative approach to medication delivery,” said
Timothy Brog, the Chief Executive Officer of Rubicon
Technology. “Although this type of transaction was not
exactly what Rubicon was looking for, the low risk and high rewards
of this investment are compelling.”
Any Rubicon Technology shareholder who orders
from Direct Dose Rx, or refers it a viable customer, will receive
for the initial order a $25 gift card to be used at Amazon,
Walgreens or CVS.
About Rubicon Technology,
Inc.
Rubicon Technology, Inc. owns Rubicon DTP LLC
and Rubicon Technology Worldwide LLC. Rubicon Technology is
also exploring various other alternatives to enhance stockholder
value, including the acquisition of an existing business,
establishing a new venture, or other investment opportunities
in order to utilize its substantial net operating losses.
Rubicon Technology Worldwide
LLC is an advanced materials provider specializing in
monocrystalline sapphire products for optical systems and specialty
electronic devices. Rubicon has a proprietary technology platform
and expertise extending from the preparation of raw aluminum oxide
through sapphire crystal growth and fabrication, enabling Rubicon
to supply custom sapphire products with superior quality and
precision. Rubicon is ISO 9001 certified and ITAR
registered.
Forward-Looking Statements
Some statements included in this news release
are forward-looking statements within the meaning of Section 27A of
the Securities Act of 1933, as amended, and Section 21E of the
Securities Exchange Act of 1934, as amended, and, therefore,
involve uncertainties or risks that could cause actual results to
differ materially therefrom. These statements may
contain words such as "desires," "believes," "anticipates,"
"plans," "expects," "intends," "estimates," “seeks,” “explores” or
similar expressions. These statements are not guarantees
of the Company's future performance and are subject to risks,
uncertainties and other important factors that could cause actual
performance or achievements to differ materially from those
expressed or implied by these forward-looking
statements. Such statements include, the pursuit or
completion of any acquisition, sale, venture transaction or
investment opportunity, or the Company’s ability to maximize the
value of its sapphire business, real estate or excess assets,
utilize its net operating losses or to enhance stockholder
value. Additional information regarding factors that could
cause results to differ materially from management's expectations
is found in the section entitled "Risk Factors" in the Company's
2018 Annual Report on Form 10-K filed with the SEC on March
22, 2019. The Company intends that the forward-looking
statements included herein be subject to the above-mentioned
statutory safe harbors. Investors are cautioned not to rely on
forward-looking statements. The Company disclaims any
obligation to update forward-looking statements.
Contact:Rubicon Technology,
Inc.Timothy E. BrogChief Executive Officer(847)
295-7000 |
Rubicon Technology (NASDAQ:RBCN)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
Rubicon Technology (NASDAQ:RBCN)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024